 |
PDBsum entry 1de7
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase substrate
|
PDB id
|
|
|
|
1de7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
28 a.a.
|
 |
|
|
|
|
|
|
|
249 a.a.
|
 |
|
|
|
|
|
|
|
26 a.a.
|
 |
|
|
|
|
|
|
|
11 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase substrate
|
 |
|
Title:
|
 |
Interaction of factor xiii activation peptide with alpha-thrombin: crystal structure of the enzyme-substrate complex
|
|
Structure:
|
 |
Alpha-thrombin (light chain). Chain: l, j. Alpha-thrombin (heavy chain). Chain: h, k. Factor xiii activation peptide (28-37). Chain: a, b. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Tissue: plasma. Synthetic: yes
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
2.00Å
|
R-factor:
|
0.194
|
R-free:
|
0.257
|
|
|
Authors:
|
 |
C.Sadasivan,V.C.Yee
|
Key ref:
|
 |
C.Sadasivan
and
V.C.Yee
(2000).
Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex.
J Biol Chem,
275,
36942-36948.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Nov-99
|
Release date:
|
13-Dec-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00734
(THRB_HUMAN) -
Prothrombin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
622 a.a.
28 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P00734
(THRB_HUMAN) -
Prothrombin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
622 a.a.
249 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H, J, K:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
275:36942-36948
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex.
|
|
C.Sadasivan,
V.C.Yee.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The serine protease thrombin proteolytically activates blood coagulation factor
XIII by cleavage at residue Arg(37); factor XIII in turn cross-links fibrin
molecules and gives mechanical stability to the blood clot. The 2.0-A resolution
x-ray crystal structure of human alpha-thrombin bound to the factor XIII-(28-37)
decapeptide has been determined. This structure reveals the detailed atomic
level interactions between the factor XIII activation peptide and thrombin and
provides the first high resolution view of this functionally important part of
the factor XIII molecule. A comparison of this structure with the crystal
structure of fibrinopeptide A complexed with thrombin highlights several
important determinants of thrombin substrate interaction. First, the P1 and P2
residues must be compatible with the geometry and chemistry of the S1 and S2
specificity sites in thrombin. Second, a glycine in the P5 position is necessary
for the conserved substrate conformation seen in both factor XIII-(28-37) and
fibrinopeptide A. Finally, the hydrophobic residues, which occupy the aryl
binding site of thrombin determine the substrate conformation further away from
the catalytic residues. In the case of factor XIII-(28-37), the aryl binding
site is shared by hydrophobic residues P4 (Val(34)) and P9 (Val(29)). A bulkier
residue in either of these sites may alter the substrate peptide conformation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Schematic representation of van der Waals
interactions ( 4 Å) of
thrombin with fXIII -(28-37) PEP1 (top) and FPA (15) (bottom).
Interactions with the underlined residues are observed only in
the given complex.
|
 |
Figure 6.
Fig. 6. Superposition of Val34 in fXIII -(28-37) and
surrounding thrombin residues. (PEP1, red; PEP2, green; FPA,
blue; PPACK, magenta). The presence of the Val34 side chain in
fXIII-(28-37) makes a shift in surrounding thrombin residues.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2000,
275,
36942-36948)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.A.Jadhav,
G.Isetti,
T.A.Trumbo,
and
M.C.Maurer
(2010).
Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment.
|
| |
Biochemistry,
49,
2918-2924.
|
 |
|
|
|
|
 |
C.Y.Koh,
M.Kazimirova,
P.A.Nuttall,
and
R.M.Kini
(2009).
Noncompetitive inhibitor of thrombin.
|
| |
Chembiochem,
10,
2155-2158.
|
 |
|
|
|
|
 |
M.D.Andersen,
M.Kjalke,
S.Bang,
I.Lautrup-Larsen,
P.Becker,
A.S.Andersen,
O.H.Olsen,
and
H.R.Stennicke
(2009).
Coagulation factor XIII variants with altered thrombin activation rates.
|
| |
Biol Chem,
390,
1279-1283.
|
 |
|
|
|
|
 |
M.I.Zavodszky,
A.Rohatgi,
J.R.Van Voorst,
H.Yan,
and
L.A.Kuhn
(2009).
Scoring ligand similarity in structure-based virtual screening.
|
| |
J Mol Recognit,
22,
280-292.
|
 |
|
|
|
|
 |
E.Di Cera
(2008).
Thrombin.
|
| |
Mol Aspects Med,
29,
203-254.
|
 |
|
|
|
|
 |
E.Di Cera,
M.J.Page,
A.Bah,
L.A.Bush-Pelc,
and
L.C.Garvey
(2007).
Thrombin allostery.
|
| |
Phys Chem Chem Phys,
9,
1291-1306.
|
 |
|
|
|
|
 |
P.S.Wells,
J.L.Anderson,
M.A.Rodger,
N.Carson,
R.L.Grimwood,
and
S.P.Doucette
(2006).
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
|
| |
Blood Coagul Fibrinolysis,
17,
533-538.
|
 |
|
|
|
|
 |
J.A.Huntington
(2005).
Molecular recognition mechanisms of thrombin.
|
| |
J Thromb Haemost,
3,
1861-1872.
|
 |
|
|
|
|
 |
G.Isetti,
and
M.C.Maurer
(2004).
Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
|
| |
J Pept Res,
63,
241-252.
|
 |
|
|
|
|
 |
B.M.Beadle,
I.Trehan,
P.J.Focia,
and
B.K.Shoichet
(2002).
Structural milestones in the reaction pathway of an amide hydrolase: substrate, acyl, and product complexes of cephalothin with AmpC beta-lactamase.
|
| |
Structure,
10,
413-424.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
| | |